Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | METAP1 | P53582 | 3/20 | 0.66 |
| ▸ | PLK4 | O00444 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.56 |
| ▸ | KDM1A | O60341 | 1/20 | 0.55 |
| ▸ | ERO1A | Q96HE7 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.53 |
| ▸ | MYC | P01106 | 1/20 | 0.53 |
| ▸ | MAX | P61244 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30020313 | 1.00 | ALDH1A1 (0.68) | ALDH1A1MAPTKMT2AMEN1METAP1 | |
| SCHEMBL30019611 | 0.86 | METAP1 (0.58) | ALDH1A1MAPTKMT2AMEN1METAP1 | |
| SCHEMBL14712974 | 0.86 | METAP1 (0.58) | ALDH1A1MAPTKMT2AMEN1METAP1 | |
| SCHEMBL10750025 | 0.84 | GSK3B (0.67) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL15421760 | 0.84 | GSK3B (0.67) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL10750021 | 0.84 | GSK3B (0.67) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL15421568 | 0.81 | KMT2A (0.79) | ALDH1A1MAPTKMT2AMEN1METAP1 | |
| SCHEMBL13848480 | 0.81 | KMT2A (1.00) | ALDH1A1MAPTKMT2AMEN1METAP1 | |
| SCHEMBL30019922 | 0.81 | KMT2A (1.00) | ALDH1A1MAPTKMT2AMEN1METAP1 | |
| SCHEMBL30020586 | 0.81 | KMT2A (0.79) | ALDH1A1MAPTKMT2AMEN1METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022245120-A1 | NOVEL COMPOUND AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR INHIBITING BIOFILM FORMATION OR VIRULENCE OF PATHOGENIC MICROORGANISM | 부산대학교 산학협력단 | 2022-11-24 | — | — | WO | claimed |
| US-20160102065-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2016-04-14 | — | — | US | claimed |
| WO-2022245120-A1 | NOVEL COMPOUND AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR INHIBITING BIOFILM FORMATION OR VIRULENCE OF PATHOGENIC MICROORGANISM | 부산대학교 산학협력단 | 2022-11-24 | — | — | WO | disclosed |
| US-10682359-B2 | Inhibitors of glucose kinases, along with methods of their formation and use | UNIVERSITY OF SOUTH CAROLINA (US) | 2020-06-16 | — | — | US | disclosed |
| US-9896421-B2 | Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2018-02-20 | — | — | US | disclosed |
| US-20160102065-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2016-04-14 | — | — | US | disclosed |
| US-9216148-B2 | Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2015-12-22 | — | — | US | disclosed |
| US-20140023603-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2014-01-23 | — | — | US | disclosed |
| US-8252490-B2 | Color filter and solid state imaging device having a colored pattern formed from a curable composition | FUJIFILM CORPORATION (JP) | 2012-08-28 | — | — | US | disclosed |
| US-8252490-B2 | Color filter and solid state imaging device having a colored pattern formed from a curable composition | FUJIFILM CORPORATION (JP) | 2012-08-28 | — | — | US | disclosed |
| EP-2036957-B1 | Pigment dispersion liquid, curable composition, color filter, produced using the same, and solid state imaging device | FUJIFILM CORP (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-7807074-B2 | Gaseous dielectrics with low global warming potentials | HONEYWELL INTERNATIONAL INC. (US) | 2010-10-05 | — | — | US | disclosed |
| CN-101601103-A | Gaseous Dielectrics with Low Global Warming Potential | HONEYWELL INT INC (US) | 2009-12-09 | — | — | CN | disclosed |
| EP-1305026-B1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | NOVUSPHARMA SPA (IT) | 2009-05-13 | — | — | EP | disclosed |
| EP-2036957-A2 | Pigment dispersion liquid, curable composition, color filter, produced using the same, and solid state imaging device | FUJIFILM Corporation (JP) | 2009-03-18 | — | — | EP | disclosed |
| US-20090017273-A1 | PIGMENT DISPERSION LIQUID, CURABLE COMPOSITION, COLOR FILTER PRODUCED USING THE SAME, AND SOLID STATE IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20090017273-A1 | PIGMENT DISPERSION LIQUID, CURABLE COMPOSITION, COLOR FILTER PRODUCED USING THE SAME, AND SOLID STATE IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20080135817-A1 | Gaseous dielectrics with low global warming potentials | HONEYWELL INTERNATIONAL INC. | 2008-06-12 | — | — | US | disclosed |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | VIA ARIOSTO, 23 (IT) | 2008-05-15 | — | — | US | disclosed |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | VIA ARIOSTO, 23 (IT) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140023603-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR | PPARG, PPARA, PPARD | ALDH1A1 186/4885MAPT 2700/4885KMT2A 3139/4885 |
| US-20160102065-A1 | NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF | PPARG, PPARA, TYR | ALDH1A1 213/4885MAPT 1956/4885KMT2A 2641/4885 |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | HIF1A, HIF1AN, PDGFA | ALDH1A1 93/4885MAPT 3423/4885KMT2A 418/4885 |
| US-10682359-B2 | Inhibitors of glucose kinases, along with methods of their formation and use | GCK, GCKR, GALK1 | ALDH1A1 3609/4885MAPT 3958/4885KMT2A 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.